Clinical Study of Recombinant Novel Coronavirus Vaccine

Condition:   Coronavirus Interventions:   Biological: Recombinant new coronavirus vaccine (CHO cell) low-dose group;   Biological: Recombinant new coronavirus vaccine (CHO cells) high-dose group;   Biological: Recombinant new coronavirus vaccine (CHO cells) placebo group Sponsor:   Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials